Entries by roaradmin

NephroGenex sold assets to Medpace Research

NephroGenex, headquartered in Raleigh, NC, is a specialty pharmaceutical Company that focused on the development of therapeutics to treat kidney disease. Based on financial considerations, the firm decided to pause its two key programs: 1) its Phase III clinical program for oral Pyridorin for the treatment of diabetic nephropathy and 2) its Phase I ready program for IV Pyridorin for the treatment of acute kidney injuries.

When things go wrong in your business, be ready to act fast

By James S. Cassel It can happen to any business owner at any time: something goes wrong. Very wrong. How do you survive and move on? The steps you take to address problems can create new dynamics that leave you in a better or worse position. Time is never your friend, so prompt, decisive action […]

HRGi received growth capital from Vesey Street Capital Partners

HRGi, headquartered in Orange, CA, provides cost containment solutions to the United States healthcare industry, serving as an intermediary between healthcare payors, such as insurance companies, and out of network healthcare providers, such as hospitals. The Company offers fee negotiation services and manages supplemental preferred provider organization networks through a proprietary single workflow, resulting in significantly lower claims expenses with minimal disruption to current workflow processes. The Company also developed ClaimSAVE, a claims scoring and valuation engine that analyzes each claim individually to identify the largest savings opportunity for each client.

Heat Biologics Announces Agreement to Acquire Pelican Therapeutics

Heat Biologics, Inc. (“Heat”) (Nasdaq:HTBX), a leader in the development of immunotherapies designed to activate a patient’s immune system against cancer, announced that the company has entered into a definitive agreement with the holders of 75.5% of the outstanding capital stock of Pelican Therapeutics, Inc. (“Pelican”) to acquire an 80% controlling interest in Pelican.